Nordiazepam

Several parent compounds including diazepam, chlordiazepoxide, clorazepate, and prazepam produce nordiazepam (desmethyldiazepam), a pharmacologically active long-acting benzodiazepine metabolite. Laboratory testing applications include drugs of abuse screening, pain management compliance monitoring, forensic toxicology investigations, postmortem toxicology, driving under the influence of drugs (DUID) cases, and clinical toxicology assessments, where nordiazepam detection helps identify the specific benzodiazepine administered and interpret the metabolic timeline. UTAK’s Benzodiazepines Plus and DAU panels contain nordiazepam in lyophilized urine and whole blood matrices at multiple concentration levels, supporting both immunoassay screening and confirmation methods. Stock and custom QC solutions can incorporate related benzodiazepines and their metabolites such as diazepam, oxazepam, temazepam, alprazolam, clonazepam, lorazepam, and other commonly monitored sedative-hypnotics to address your laboratory’s comprehensive benzodiazepine testing requirements.